• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

    2.190 -0.050 (-2.23%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,384
    Open 2.280
    Bid (Size) 2.150 (2,000)
    Ask (Size) 2.280 (100)
    Prev. Close 2.240
    Today's Range 2.190 - 2.280
    52wk Range 1.650 - 3.065
    Shares Outstanding 5,567,490
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
    Via ACCESS Newswire

    Performance

    YTD
    -20.9%
    -20.9%
    1 Month
    -10.2%
    -10.2%
    3 Month
    -15.8%
    -15.8%
    6 Month
    -3.9%
    -3.9%
    1 Year
    +8.4%
    +8.4%

    More News

    Read More
    News headline image
    Aytu (AYTU) Q3 2026 Earnings Transcript ↗
    Via The Motley Fool
    Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results ↗
    Via Chartmill
    Aytu BioPharma Inc (NASDAQ:AYTU) Posts Q2 Revenue Beat Amid EXXUA Launch Costs ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    News headline image
    Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma AYTU Q2 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Recaps Investor Day Held on January 20, 2026
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗
    Via Chartmill
    News headline image
    Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
    Via ACCESS Newswire
    News headline image
    Insights into Aytu BioPharma's Upcoming Earnings ↗
    Via Benzinga
    News headline image
    Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Present at Upcoming October 2025 Conferences
    Via ACCESS Newswire
    News headline image
    11 Company Presentations Today at The MicroCap Rodeo Conference
    Via ACCESS Newswire
    News headline image
    Aytu BioPharma to Present at Upcoming September 2025 Conferences
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Aytu BioPharma, Inc. - Common Stock publicly traded?
    Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
    What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
    Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
    The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
    What is the current price of Aytu BioPharma, Inc. - Common Stock?
    The current price of Aytu BioPharma, Inc. - Common Stock is 2.190
    When was Aytu BioPharma, Inc. - Common Stock last traded?
    The last trade of Aytu BioPharma, Inc. - Common Stock was at 06/11/26 04:00 PM ET
    What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
    The market capitalization of Aytu BioPharma, Inc. - Common Stock is 12.19M
    How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
    Aytu BioPharma, Inc. - Common Stock has 12M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.